|
Use of Hand Extension Rubber During Intravenous Catheter Placement
RECRUITINGN/ASponsored by Necmettin Erbakan University
Actively Recruiting
PhaseN/A
SponsorNecmettin Erbakan University
Started2026-06-15
Est. completion2026-08-01
Eligibility
Age18 Years – 65 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07659015
Summary
The study aims to investigate the effect of a hand extension rubber used in patients with peripheral intravenous catheters on pain, anxiety, and satisfaction.
Eligibility
Age: 18 Years – 65 YearsHealthy volunteers accepted
Inclusion Criteria: * Volunteers willing to participate in the study * Patients aged 18-65 * Patients who are alert and able to communicate verbally in Turkish * Patients assigned to the green zone during triage * Patients suitable for PICC placement in the left cephalic and basilic veins * Patients who are right-handed * Patients with a VAS pain score of 0 prior to the PIC procedure Exclusion Criteria: * Patients with acute or chronic pain * Patients with conditions that cause limited mobility, such as muscle disorders or grip dysfunction * Patients with peripheral neuropathy, arteriovenous fistula, or bilateral mastectomy * Patients with a psychiatric diagnosis (as self-reported) * Patients with communication impairments (hearing, speech, and vision) * Patients with a history of negative PIC procedure experiences Terminating Criteria: * Participants wishing to withdraw from the study at any stage after giving their consent * Failure of the PIC procedure * Failure to use the hand extension band until the end of the procedure * Occurrence of complications related to the PIC procedure during the procedure
Conditions3
AnxietyPainSatisfaction
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhaseN/A
SponsorNecmettin Erbakan University
Started2026-06-15
Est. completion2026-08-01
Eligibility
Age18 Years – 65 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT07659015